Literature DB >> 32610061

Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles.

David C Luther1, Rui Huang1, Taewon Jeon2, Xianzhi Zhang1, Yi-Wei Lee1, Harini Nagaraj1, Vincent M Rotello3.   

Abstract

Inorganic nanoparticles provide multipurpose platforms for a broad range of delivery applications. Intrinsic nanoscopic properties provide access to unique magnetic and optical properties. Equally importantly, the structural and functional diversity of gold, silica, iron oxide, and lanthanide-based nanocarriers provide unrivalled control of nanostructural properties for effective transport of therapeutic cargos, overcoming biobarriers on the cellular and organismal level. Taken together, inorganic nanoparticles provide a key addition to the arsenal of delivery vectors for fighting disease and improving human health.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Drug delivery; Gold; Inorganic nanoparticles; Iron oxide; Lanthanide upconversion particles; Silica

Year:  2020        PMID: 32610061     DOI: 10.1016/j.addr.2020.06.020

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  25 in total

1.  High affinity protein surface binding through co-engineering of nanoparticles and proteins.

Authors:  Moumita Ray; Giorgia Brancolini; David C Luther; Ziwen Jiang; Roberto Cao-Milán; Alejandro M Cuadros; Andrew Burden; Vincent Clark; Subinoy Rana; Rubul Mout; Ryan F Landis; Stefano Corni; Vincent M Rotello
Journal:  Nanoscale       Date:  2022-02-10       Impact factor: 7.790

2.  Direct Cytosolic Delivery of Proteins Using Lyophilized and Reconstituted Polymer-Protein Assemblies.

Authors:  David C Luther; Harini Nagaraj; Ritabrita Goswami; Yağız Anıl Çiçek; Taewon Jeon; Sanjana Gopalakrishnan; Vincent M Rotello
Journal:  Pharm Res       Date:  2022-03-16       Impact factor: 4.200

Review 3.  Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer.

Authors:  Jingyue Yan; Diana D Kang; Gillian Turnbull; Yizhou Dong
Journal:  Adv Drug Deliv Rev       Date:  2021-11-09       Impact factor: 15.470

Review 4.  Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives.

Authors:  Madhusudhan Alle; Garima Sharma; Seung-Hwan Lee; Jin-Chul Kim
Journal:  J Nanobiotechnology       Date:  2022-07-02       Impact factor: 9.429

5.  Theoretical analysis of the structural and electronic properties of the interaction of boron nitride diamantane nanocrystal with the drug hydroxyurea as an anticancer drug.

Authors:  Haider O Muhsen; Ali Obies Muhsen Almayyali; Ammar Yahya Al-Mamoori; Fatin Fadhel Mahmood
Journal:  J Mol Model       Date:  2021-02-21       Impact factor: 1.810

Review 6.  Protein Delivery: If Your GFP (or Other Small Protein) Is in the Cytosol, It Will Also Be in the Nucleus.

Authors:  David C Luther; Taewon Jeon; Ritabrita Goswami; Harini Nagaraj; Dongkap Kim; Yi-Wei Lee; Vincent M Rotello
Journal:  Bioconjug Chem       Date:  2021-04-19       Impact factor: 4.774

7.  Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier.

Authors:  Anshul Dhankher; Wei Lv; William T Studstill; Julie A Champion
Journal:  J Control Release       Date:  2021-09-24       Impact factor: 9.776

Review 8.  In situ activation of therapeutics through bioorthogonal catalysis.

Authors:  Wenjie Wang; Xianzhi Zhang; Rui Huang; Cristina-Maria Hirschbiegel; Huaisong Wang; Ya Ding; Vincent M Rotello
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

9.  Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.

Authors:  Jacob S Brenner; Samir Mitragotri; Vladimir R Muzykantov
Journal:  Annu Rev Biomed Eng       Date:  2021-03-31       Impact factor: 11.324

10.  Genetically Modified Ferritin Nanoparticles with Bone-Targeting Peptides for Bone Imaging.

Authors:  Jong-Won Kim; Kyung-Kwan Lee; Kyoung-Woo Park; Moonil Kim; Chang-Soo Lee
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.